Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  INC Research Holdings Inc    INCR

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Glancy Prongay & Murray LLP : Continues Investigation on Behalf of INC Research Holdings, Inc. Investors (INCR)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/10/2017 | 09:01pm CET

Glancy Prongay & Murray LLP (“GPM”) continues its investigation on behalf of INC Research Holdings, Inc. (“INCR” or the “Company”) (NASDAQ: INCR) investors concerning the Company and its officers’ possible violations of federal securities law. To obtain information or aid in the investigation, please visit the INCR page on our website at https://www.glancylaw.com/case/inc-research-holdings-inc.

On November 9, 2017, INC Research reported its first financial results after combining with inVentiv Health. The Company’s combined results were negatively impacted by merger-related expenses, an impairment charge and increased amortization expenses. The price of INC Research stock fell significantly following the announcement.

On this news, INCR’s stock price fell nearly 30%, or $16.35 per share, to close at $41.15 per share on November 9, 2017, thereby injuring investors.

If you purchased INCR securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley F. Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to [email protected], or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.


© Business Wire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on INC RESEARCH HOLDINGS INC
11/17 INC RESEARCH HOLDINGS, INC. (NASDAQ : INCR) Files An 8-K Departure of Directors ..
11/17 INC RESEARCH HOLDINGS, INC. : Change in Directors or Principal Officers, Financi..
11/16 Investigation of INC Research Holdings Announced by Holzer & Holzer
11/16 RESEARCH : Glancy Prongay & Murray LLP Commences Investigation on Behalf of INC ..
11/13 INCR Law Offices of Howard G. Smith Continues Investigation on Behalf of INC ..
11/13 INC RESEARCH HOLDINGS INC : Bronstein, Gewirtz & Grossman, LLC Announces Investi..
11/12 Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possib..
11/10 Rosen Law Firm Announces Investigation of Securities Claims Against INC Resea..
11/10 GLANCY PRONGAY & MURRAY LLP : Continues Investigation on Behalf of INC Research ..
11/10 Bronstein, Gewirtz & Grossman, LLC Announces Investigation of INC Research Ho..
More news
News from SeekingAlpha
11/10 INC Research Holdings 2017 Q3 - Results - Earnings Call Slides
11/09 INC Research's (INCR) CEO Alistair MacDonald on Q3 2017 Results - Earnings Ca..
11/09 Midday Gainers / Losers
11/09 INC Research misses by $0.08, misses on revenue
11/08 Notable earnings before Thursday?s open
Financials ($)
Sales 2017 3 087 M
EBIT 2017 489 M
Net income 2017 117 M
Debt 2017 2 707 M
Yield 2017 -
P/E ratio 2017 25,66
P/E ratio 2018 32,07
EV / Sales 2017 2,13x
EV / Sales 2018 1,97x
Capitalization 3 882 M
Chart INC RESEARCH HOLDINGS INC
Duration : Period :
INC Research Holdings Inc Technical Analysis Chart | INCR | US45329R1095 | 4-Traders
Technical analysis trends INC RESEARCH HOLDINGS INC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Average target price 53,8 $
Spread / Average Target 44%
EPS Revisions
Managers
NameTitle
Alistair Macdonald Chief Executive Officer & Director
Michael A. Bell Executive Chairman & President-Commercial Division
Michael Gibertini Chief Operating Officer
Gregory S. Rush Chief Financial Officer & Executive Vice President
Robert W. Breckon Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
INC RESEARCH HOLDINGS INC-28.23%3 882
CELLTRION, INC.--.--%24 243
IQVIA HOLDINGS INC37.36%21 955
INCYTE CORPORATION5.19%20 882
LONZA GROUP59.15%19 698
ALNYLAM PHARMACEUTICALS, INC.240.57%12 601